The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,554.96 firm fixed-price delivery order is for the supply of 4564450204 - Hydroxyzine 10 mg/5 ml Syrup 473 ml, with a completion date of May 1, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $12,714.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565218807 - Hydroxyzine 10 mg/5 ml Syrup 473 ml, a pharmaceutical product. The contract has an ultimate completion date of July 23, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside designation. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,056.49 firm fixed-price delivery order is for the delivery of hydroxyzine 50 mg/ml vials. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $3,715.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4565295944 - Hydroxyzine 10 mg/5 ml syrup 473 ml to support military treatment programs and facilities. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award, with ID SPE2DB22D2214|SPE2DB23FS6HM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.35 Firm Fixed Price Delivery Order is for the supply of 4562280379 - Hydroxyzine 10 mg/5 ml Syrup 473 ml. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, to provide a specific medication - Hydroxyzine 10 mg/5 ml Syrup 473 ml. The contract is a firm fixed price delivery order with a ceiling value of $15,835.11 and a performance period through March 20, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,031.63 firm-fixed-price delivery order is for the supply of 4564543487 HYDROXYZINE 10 MG/5 ML SYRUP 473ML, with a period of performance through May 9, 2024. The contract is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,532.05, is for the delivery of Hydroxyzine 10 mg/5 ml syrup in 473 ml quantities. The contract has an ultimate completion date of March 7, 2024, and utilizes a firm fixed-price delivery order pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $7,169.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of hydroxyzine 50 mg/ml vials, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,845.23 firm fixed-price delivery order is for the supply of 473 ml of 10 mg/5 ml hydroxyzine syrup. The contract has no set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...